Nuclear accumulation of prohibitin 1 in osteoarthritic chondrocytes down-regulates PITX1 expression

Arthritis and Rheumatism

Volumn 65, Issue 4, 2013, Pages 993-1003

  Picard, Cynthia ^a   Pellicelli, Martin ^a   Taheri, Maryam ^a   Lavoie, Jean Francois ^a   Doucet, Roxanne ^a   Wang, Dashen ^a   Bernard, Lauriane ^a   Bouhanik, Saadallah ^a   Lavigne, Patrick ^b   Moreau, Alain ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PITX1 PROTEIN; PROHIBITIN; PROHIBITIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BINDING SITE; CARTILAGE CELL; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSCRIPTION INITIATION SITE; UPREGULATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARTILAGE, ARTICULAR; CASE-CONTROL STUDIES; CHONDROCYTES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; E2F1 TRANSCRIPTION FACTOR; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICE; MIDDLE AGED; OSTEOARTHRITIS; OSTEOARTHRITIS, KNEE; PAIRED BOX TRANSCRIPTION FACTORS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; YOUNG ADULT;

EID: 84875419951     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37837     Document Type: Article

References (26)

1. Lanctot C, Moreau A, Chamberland M, Tremblay ML, Drouin J,. Hindlimb patterning and mandible development require the Ptx1 gene. Development 1999; 126: 1805-10.
2. Picard C, Azeddine B, Moldovan F, Martel-Pelletier J, Moreau A,. New emerging role of pitx1 transcription factor in osteoarthritis pathogenesis. Clin Orthop Relat Res 2007; 462: 59-66.
3. Mishra S, Murphy LC, Nyomba BL, Murphy LJ,. Prohibitin: a potential target for new therapeutics. Trends Mol Med 2005; 11: 192-7.
4. Mishra S, Murphy LC, Murphy LJ,. The prohibitins: emerging roles in diverse functions. J Cell Mol Med 2006; 10: 353-63.
5. Nijtmans LG, Artal SM, Grivell LA, Coates PJ,. The mitochondrial PHB complex: roles in mitochondrial respiratory complex assembly, ageing and degenerative disease. Cell Mol Life Sci 2002; 59: 143-55.
6. Artal-Sanz M, Tavernarakis N,. Prohibitin and mitochondrial biology. Trends Endocrinol Metab 2009; 20: 394-401.
7. Osman C, Merkwirth C, Langer T,. Prohibitins and the functional compartmentalization of mitochondrial membranes. J Cell Sci 2009; 122: 3823-30.
8. Wang S, Nath N, Fusaro G, Chellappan S,. Rb and prohibitin target distinct regions of E2F1 for repression and respond to different upstream signals. Mol Cell Biol 1999; 19: 7447-60.
9. Wang S, Fusaro G, Padmanabhan J, Chellappan SP,. Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression. Oncogene 2002; 21: 8388-96.
10. Wang S, Zhang B, Faller DV,. Prohibitin requires Brg-1 and Brm for the repression of E2F and cell growth. EMBO J 2002; 21: 3019-28.
11. Choi D, Lee SJ, Hong S, Kim IH, Kang S,. Prohibitin interacts with RNF2 and regulates E2F1 function via dual pathways. Oncogene 2008; 27: 1716-25.
12. Fusaro G, Dasgupta P, Rastogi S, Joshi B, Chellappan S,. Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J Biol Chem 2003; 278: 47853-61.
13. Rastogi S, Joshi B, Dasgupta P, Morris M, Wright K, Chellappan S,. Prohibitin facilitates cellular senescence by recruiting specific corepressors to inhibit E2F target genes. Mol Cell Biol 2006; 26: 4161-71.
14. Altman RD, Meenan RF, Hochberg MC, Bole GG Jr, Brandt K, Cooke TD, et al. Development of clinical criteria for osteoarthritis. J Rheumatol 1987;14 Spec No:3-6.
15. Finger F, Schorle C, Zien A, Gebhard P, Goldring MB, Aigner T,. Molecular phenotyping of human chondrocyte cell lines T/C-28a2, T/C-28a4, and C-28/I2. Arthritis Rheum 2003; 48: 3395-403.
16. INK4a. Cell 1997; 88: 593-602.
17. Bossy-Wetzel E, Barsoum MJ, Godzik A, Schwarzenbacher R, Lipton SA,. Mitochondrial fission in apoptosis, neurodegeneration and aging. Curr Opin Cell Biol 2003; 15: 706-16.
18. Blanco FJ, Lopez-Armada MJ, Maneiro E,. Mitochondrial dysfunction in osteoarthritis. Mitochondrion 2004; 4: 715-28.
19. Mason RM, Chambers MG, Flannelly J, Gaffen JD, Dudhia J, Bayliss MT,. The STR/ort mouse and its use as a model of osteoarthritis. Osteoarthritis Cartilage 2001; 9: 85-91.
20. Allen TD, Cronshaw JM, Bagley S, Kiseleva E, Goldberg MW,. The nuclear pore complex: mediator of translocation between nucleus and cytoplasm. J Cell Sci 2000; 113: 1651-9.
21. Rastogi S, Joshi B, Fusaro G, Chellappan S,. Camptothecin induces nuclear export of prohibitin preferentially in transformed cells through a CRM-1-dependent mechanism. J Biol Chem 2006; 281: 2951-9.
22. Kartha GK, Moshal KS, Sen U, Joshua IG, Tyagi N, Steed MM, et al. Renal mitochondrial damage and protein modification in type-2 diabetes. Acta Diabetol 2008; 45: 75-81.
23. Merkwirth C, Langer T,. Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis. Biochim Biophys Acta 2009; 1793: 27-32.
24. Coates PJ, Jamieson DJ, Smart K, Prescott AR, Hall PA,. The prohibitin family of mitochondrial proteins regulate replicative lifespan. Curr Biol 1997; 7: 607-10.
25. Martin JA, Buckwalter JA,. Aging, articular cartilage chondrocyte senescence and osteoarthritis. Biogerontology 2002; 3: 257-64.
26. Johnson K, Jung A, Murphy A, Andreyev A, Dykens J, Terkeltaub R,. Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization. Arthritis Rheum 2000; 43: 1560-70.